8 results
Summary of characteristics of Platelet Aggregation Inhibitors

#AntiPlatelet #Inhibitors #Pharmacology #Table #Overview #Interactions #Pharmacology #Cardiology
AntiPlatelet #Inhibitors #Pharmacology ... #Table #Overview ... #Interactions #Pharmacology ... #Cardiology
Warfarin color-coded tablets, initial dosing and INR targets

#pharmacology #overview #review #medications #drugs #cardiology #warfarin #management
INR targets #pharmacology ... #overview #review ... medications #drugs #cardiology
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
#Medications #Cardiology ... #Pharmacology # ... Therapy #Table #Overview
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
effects of ACEIs, leading ... alpha-blockers, leading ... betablockers, leading ... supplementals #herbal #pharmacology ... #DDI #table #cardiology
Beta Blockers Overview - Beta Adrenergic Antagonists
Cardioselective:
M - Metoprolol 
A - Atenolol 
N - Nebivolol 
B
Beta Blockers Overview ... NonSelective #Mnemonic #Pharmacology ... #MANBABE #Cardiology
Antiarrhythmics Pharmacology Summary
Cardiac Conduction Phases:
Phase 0 - Ventricular Depolarization:
 • Na+ channels open leading to a
Antiarrhythmics Pharmacology ... channels open leading ... inotropy) ACCP Cardiology ... Antiarrhythmics #Pharmacology ... pathophysiology #phases #cardiology
Iron Deficiency in Congestive Heart Failure (CHF)

Iron deficiency (ID) in heart failure is a common comorbidity
50% of patients, leading ... #Failure #CHF #pharmacology ... pathophysiology #cardiology
Digoxin Dosing - Pharmacology

Loading: 0.5 mg IV followed by 0.25 mg IV q6h x 2
Maintenance: 0.125
Digoxin Dosing - Pharmacology ... Loading: 0.5 mg ... Digoxin #Dosing #Pharmacology ... #loading #maintenance ... #cardiology